Monopar Therapeutics (MNPR) Cash & Equivalents (2016 - 2025)
Quarterly results put Cash & Equivalents at $61.8 million for Q4 2025, up 34.96% from a year ago — trailing twelve months through Dec 2025 was $61.8 million (up 34.96% YoY), and the annual figure for FY2025 was $61.8 million, up 34.96%.
Monopar Therapeutics has reported Cash & Equivalents over the past 10 years, most recently at $61.8 million for Q4 2025.
- Cash & Equivalents reached $61.8 million in Q4 2025 per MNPR's latest filing, down from $127.7 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $127.7 million in Q3 2025 and bottomed at $5.5 million in Q3 2023.
- Median Cash & Equivalents over the past 5 years was $17.1 million (2022), compared with a mean of $25.4 million.
- The largest annual shift saw Cash & Equivalents plummeted 67.87% in 2023 before it soared 2020.86% in 2025.
- Over 5 years, Cash & Equivalents stood at $20.0 million in 2021, then crashed by 59.1% to $8.2 million in 2022, then fell by 11.24% to $7.3 million in 2023, then skyrocketed by 530.55% to $45.8 million in 2024, then skyrocketed by 34.96% to $61.8 million in 2025.
- Business Quant data shows Cash & Equivalents for MNPR at $61.8 million in Q4 2025, $127.7 million in Q3 2025, and $39.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 1.91 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 901.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 5.49 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.96 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.71 Bn |
| 10 | Monopar Therapeutics | 466.82 Mn | 466.82 Mn | - | 61.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 61.83 Mn |
| Sep 30, 2025 | 127.68 Mn |
| Jun 30, 2025 | 39.50 Mn |
| Mar 31, 2025 | 39.71 Mn |
| Dec 31, 2024 | 45.82 Mn |
| Sep 30, 2024 | 6.02 Mn |
| Jun 30, 2024 | 6.12 Mn |
| Mar 31, 2024 | 7.81 Mn |
| Dec 31, 2023 | 7.27 Mn |
| Sep 30, 2023 | 5.52 Mn |
| Jun 30, 2023 | 7.21 Mn |
| Mar 31, 2023 | 5.73 Mn |
| Dec 31, 2022 | 8.19 Mn |
| Sep 30, 2022 | 13.92 Mn |
| Jun 30, 2022 | 16.46 Mn |
| Mar 31, 2022 | 17.82 Mn |
| Dec 31, 2021 | 20.01 Mn |
| Sep 30, 2021 | 22.34 Mn |
| Jun 30, 2021 | 23.84 Mn |
| Mar 31, 2021 | 25.72 Mn |
| Dec 31, 2020 | 16.74 Mn |
| Sep 30, 2020 | 17.98 Mn |
| Jun 30, 2020 | 12.55 Mn |
| Mar 31, 2020 | 12.59 Mn |
| Dec 31, 2019 | 13.21 Mn |
| Sep 30, 2019 | 4.49 Mn |
| Jun 30, 2019 | 5.13 Mn |
| Mar 31, 2019 | 5.88 Mn |
| Dec 31, 2018 | 6.89 Mn |
| Sep 30, 2018 | 7.62 Mn |
| Jun 30, 2018 | 8.22 Mn |
| Mar 31, 2018 | 8.97 Mn |
| Dec 31, 2017 | 8.98 Mn |
| Sep 30, 2017 | 10.59 Mn |
| Jun 30, 2017 | 4.28 Mn |
| Mar 31, 2017 | 3.55 Mn |
| Dec 31, 2016 | 2.87 Mn |